See full prescribing information for yorvipath. Conventional therapy for hypoparathyroidism consists of active vitamin d (e.g., calcitriol or its analog alfacalcidol) and calcium supplementation. Yorvipath is indicated for the treatment of hypoparathyroidism in adults
Forrest Smith
The fda has approved yorvipath (palopegteriparatide) injection for subcutaneous use in adults with hypoparathyroidism
